# Dexmedetomidine and Magnesium Sulfate in the Reduction Cognitive Dysfunction in Geriatrics

> **NCT06702488** · PHASE1 · RECRUITING · sponsor: **Fayoum University** · enrollment: 58 (estimated)

## Conditions studied

- Mental Disorder

## Interventions

- **DRUG:** dexmedetomidine

## Key facts

- **NCT ID:** NCT06702488
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-21
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-15
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06702488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06702488, "Dexmedetomidine and Magnesium Sulfate in the Reduction Cognitive Dysfunction in Geriatrics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06702488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*